- Home
- Medical news
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Medical Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Medical Education
- Industry
- Case of the Day
- Editorial
Abbott India MD Rehan A Khan resigns

Drug firm Abbott India today announced the resignation of its Managing Director Rehan A Khan."Rehan A Khan has vide his letter dated February 29, 2016, tendered resignation as the Managing Director and Director of the company to pursue career opportunity overseas," Abbott India said in a BSE filing.His resignation shall be effective close of business hours on April 30, 2016, it added.In...
Drug firm Abbott India today announced the resignation of its Managing Director Rehan A Khan.
"Rehan A Khan has vide his letter dated February 29, 2016, tendered resignation as the Managing Director and Director of the company to pursue career opportunity overseas," Abbott India said in a BSE filing.
His resignation shall be effective close of business hours on April 30, 2016, it added.
In another development, Kaiyomarz Marfatia has ceased to be a whole-time director of the company upon completion of his term with effect from February 29, 2016, Abbott India said.
"He continues as the non-executive director of the company, subject to retirement by rotation," it added.
Abbott India stock today closed 0.48 per cent down at Rs 4,792.45 on BSE
"Rehan A Khan has vide his letter dated February 29, 2016, tendered resignation as the Managing Director and Director of the company to pursue career opportunity overseas," Abbott India said in a BSE filing.
His resignation shall be effective close of business hours on April 30, 2016, it added.
In another development, Kaiyomarz Marfatia has ceased to be a whole-time director of the company upon completion of his term with effect from February 29, 2016, Abbott India said.
"He continues as the non-executive director of the company, subject to retirement by rotation," it added.
Abbott India stock today closed 0.48 per cent down at Rs 4,792.45 on BSE
Abbott Healthcare Abbott India Managing Director and Director of the company Rehan A Khan resignation
Next Story
NO DATA FOUND